Abstract-Resistance to angiotensin II (Ang II)-induced hypertension in T-cell-deficient male mice with a targeted mutation in the recombination-activating gene-1 (Rag1) on the C57BL/6J background (B6.Rag1
T he Rag1 gene codes for an enzyme that plays a critical role in the formation of the T-cell receptor, and this protein is required for generating mature T and B cells. 1 In 2007, David Harrison's laboratory, then at Emory, published that the increase in systolic blood pressure (SBP) induced by angiotensin II (Ang II) infusion was greater in male wildtype mice (WT-M) compared with male Rag1 knockout mice (Rag1 −/− -M) on the C57BL/6J background strain purchased from Jackson Laboratory. 2 Two weeks of Ang II infusion at 490 ng/kg per minute caused a 41±3 mm Hg increase in SBP in WT-M, whereas the SBP increased by only 21±1 mm Hg in
Rag1
−/− -M.
−/− -M resistance to Ang II-induced hypertension was replicated by several independent laboratories including us at Georgetown University, Washington, DC, 3 and investigators at the University of Kentucky, 4 Louisiana State University, Shreveport 5 and at the University of Arizona, Tucson 6 regardless of how blood pressure was measured including by tail cuff, 2,4,6 a pressure transducer via an implanted femoral artery catheter 5 or by telemetry. 3 All of these studies were conducted on male B6.129S7-Rag1 tm1Mom /J (B6.Rag1 −/− -M) purchased from Jackson Laboratory before 2015. Here we report on the loss of this phenotype. B6.Rag1 −/− -M purchased in 2015 and 2016 are no longer resistant to Ang II-induced increases in blood pressure. We also discuss the implications for investigators using the B6.Rag1 −/− -M to study immune modulation of blood pressure.
Methods

Mice
Source
Jackson Laboratory reports that the Rag1 tm1Mom mutant strain was developed by Dr Peter Mombaerts at the Massachusetts Institute of Technology. 7 Homologous recombination of the targeting vector with the Pgk-neo marker resulted in a 5′ deletion of 1356 bp in the coding sequence in the 129S7/SvEvBrd-Hprt + -derived AB1 embryonic stem cell line. Backcrossing mice carrying the Rag1 tm1Mom mutation a minimum of 10× to C57BL/6J inbred mice resulted in the generation of B6.Rag1 tm1Mom (B6.Rag1 June 2017
Diet
At Jackson Laboratories, the B6.Rag1 −/− and B6.WT mice were maintained on LabDiet 5K52 (22% protein, 16% fat, and 62% carbohydrates). According to Jackson Laboratories, there have been no changes to the formulation of this diet since the life of this mouse line. Once these mice arrived at Georgetown University, they were maintained on LabDiet 5053 (24% protein, 13% fat, and 62% carbohydrates). Both of these diets were purchased from LabDiet (St. Louis, MO).
Housing
Both at Jackson Laboratories and Georgetown University, the B6.Rag1 −/− and B6.WT littermates were maintained in a pathogenfree barrier facility. Ivanov et al 8 reported that mice from Jackson Laboratories are free of segmented filamentous bacteria (SFB), which influence Th17 cells and subsequent studies have confirmed this finding. 9 Jackson Laboratories reports that in 2013, they tested all of their foundation stocks and animal rooms for SFB and failed to find any positive results for SFB. Since September 2015, they regularly test their mouse rooms for SFB and also have yet to find any positive results. Thus, it is unlikely that there was any difference in the SFB status of recently purchased B6.Rag1 −/− -M and those purchased before 2015.
All experimental methods were approved by the Georgetown University Animal Care and Use Committee.
Genotyping
Genomic DNA was extracted from mouse tails, as described previously. 10 Polymerase chain reaction was used to genotype B6.Rag1
The B6.WT forward primer (oIMR1746) was 5′-GAG GTT CCG CTA CGA CTC TG-3′. The B6.Rag1 −/− forward primer (oIMR8162) was 5′-TGG ATG TGG AAT GTG TGC GAG-3′. The common reverse primer (oIMR3104) was 5′-CCG GAC AAG TTT TTC ATC GT-3′. Polymerase chain reaction cycling was as follows: 94°C for 2 minutes then 35 cycles of 94°C for 30 s, 58°C for 45 s, 72°C for 45 s, and 1 elongation cycle of 72°C for 2 minutes. The B6.WT and disrupted alleles in the B6.Rag1 −/− generated amplicons of 474 bp and 530 bp, respectively. -M, as we previously described. 11 Recording began on the fifth to seventh day after transmitter implantation. Recordings were taken at 30-s intervals every 10 minutes from 6 pm to 6 am and presented as daily averages using a Data Acquisition and Analysis System (Data Sciences Int.).
Mean Arterial Pressure and Heart Rate Measurements
Ang II Infusion
After recording a stable basal mean arterial pressure (MAP) for at least 3 days, Alzet osmotic minipumps (model no. 1002; 100 μL reservoir vol; 0.25 μL/h; Durect Corporation, Cupertino, CA) filled with Ang II (Sigma, Saint Louis, MO; no. A9525) dissolved in saline were implanted under isoflurane anesthesia. After 2 weeks of Ang II infusion at 200 ng/kg per minute, pumps were removed and exchanged with new pumps infusing Ang II at 490 ng/kg per minute. A subset of the mice received a pump with the Ang II dose of 75 ng/kg per minute. At the termination of the experiment, mice were euthanized and the spleens were collected along with whole blood.
Isolation From Peripheral Blood Mononuclear Cells and T Cells From Spleen
Peripheral blood mononuclear cells were isolated from whole blood using red blood cell lysis buffer, and CD3 + T cells were isolated from spleen by negative magnetic sorting (Pan T-cell Isolation Kit II, Miltenyi, Auburn, CA) from single-cell suspensions of splenocytes, as we previously described. 3 
Isolation of Glomeruli
Glomeruli were isolated from whole kidneys as we described previously 12 with the following modifications: mesh sizes for mouse kidneys were 125 μm (mesh size no. 120) for initial sieving followed by 2 stacks of sieves with 150 μm (mesh size no. 100) on the top and 63 μm (sieve size no. 230) on the bottom. The glomeruli were collected in a glass beaker from the bottom mesh by rinsing the mesh with ice-cold phosphate-buffered saline in the presence of protease inhibitors (Final concentrations: 0.2 μmol/L phenylmethyl-sulfonyl fluoride, 1 μg/mL leupeptin, 2 μg/mL antipain, and 1 U/L aprotinin). The glomeruli were then centrifuged in 50 mL tubes at 3000 rpm for 15 minutes. The supernatant was removed by vacuum, and the pellet was washed with phosphate-buffered saline and recentrifuged in a 1.5-mL microcentrifuge tube at 12 000 rpm for 10 minutes. The final pellet was resuspended in homogenization buffer (50 mmol/L TRIS-HCl, 1 mmol/L EDTA buffer, pH 7.4) and supplemented with protease inhibitors (Final concentrations: 0.2 μmol/L phenylmethyl-sulfonyl fluoride, 1 μg/mL leupeptin, 2 μg/mL antipain, and 1 U/L aprotinin). Protein concentrations of isolated glomeruli were determined by the Bradford method using bovine serum albumin as the standard (Bio-Rad Laboratories, Richmond, CA). 
Statistical Analysis
Literature Search
Searches of OVID and PubMed were conducted in journals through January 3, 2017. All languages were included, and no start date was imposed in the search. Two separate searches were performed before Boolean logic was applied:
1. Recombination-activating gene OR Rag 2. Blood pressure OR arterial pressure OR systolic pressure OR hypertension Boolean logic: (1) AND (2). Two reviewers (AVP and KS) independently performed the search and analyzed the results.
Results
Genotyping
Polymerase chain reaction of the Rag1 −/− gene showed that DNA extracted from B6.Rag1 
Systematic Review
Through a systematic literature search, 17 unique records were identified that cited use of Rag1 −/− and measurement of blood pressure. All were screened. Sixteen publications included original data and of these (Table), (Table) . One paper 14 reported that adoptive transfer of B6.WT CD3 + T cells into B6.Rag1 −/− restored the hypertensive response to Ang II to a level observed in Ang II-infused B6.WT; however, these data were not shown.
Discussion
The main finding of this report is that compared with their male B6.WT littermates, B6.Rag1 −/− -M purchased from Jackson Laboratory in 2015 and 2016 were no longer resistant to Ang II-induced hypertension (Figure 3 ). This finding is in stark contrast to our previous results 3 (Table) .
Our new data suggest that a genetic drift has occurred in the Jackson Laboratory B6.129S7-Rag1 tm1Mom /J mouse strain (catalog no. 002216), which has led to a loss of resistance (Figure 4) , and low numbers of peripheral blood mononuclear cells confirm that these mice were deficient in their ability to produce mature T cells.
A recently published study by Mian et al 13 at McGill University supports our current observation. Using tail-cuff assessments of SBP, they showed that 2 weeks of Ang II infusion at 490 ng/kg per minute in the B6.Rag1 −/− -M caused a 37 mm Hg increase in SBP (Table) . This increase in SBP was markedly larger than the previous reports using the tail-cuff method, including studies by Guzik et al 2 (∆21 mm Hg), Trott et al 16 (∆24 mm Hg), and Pollow et al. 6 (∆22 mm Hg; Table) . Mian et al 13 did not compare the magnitude of SBP increases induced by Ang II infusion in B6.Rag1 ; however, this study infused a high dose of Ang II (1000 ng/kg per minute). We previously showed that B6.Rag1 −/− -M resistance to Ang II-induced increases in blood pressure is dependent on the dose of Ang II. 3 Although we showed that blood pressure in B6.Rag1
−/− -M purchased in 2011 and 2012 is resistant to elevation by slow pressor doses of Ang II (200 and 490 ng/kg per minute), we observed no differences in blood pressure elevation at the 1000 ng/kg per minute Ang II dose. 3 In contrast, in the mice purchased in 2015 and 2016, no differences in the elevation of MAP were observed between B6.WT-M and B6.Rag1 −/− -M at the lowest dose of Ang II (200 ng/kg per minute) that caused an increase in MAP ( Figure 3A) . Note that at 75 ng/kg per minute, Ang II did not significantly increase MAP in either strains.
In an effort to improve rigor and reproducibility of scientific research, the National Institutes of Health now requires grant applicants to report experimental details to ensure full transparency in interpreting results (https://grants.nih.gov/reproducibility/index.htm). A section on the authentication of key biological resources is also now required in all grant applications. Our findings indicate that in addition to using the standardized genetic nomenclature system to accurately describe mouse genes, mutations and strains (http://www.informatics.jax.org), experimental details of animal studies should also include the source, location, and time period over which animals are bred.
Diet is also important to report, especially, because new studies suggest that the microbiota can influence the blood pressure sensitivity to Ang II. Karbach et al 18 recently showed that blood pressure responses to Ang II were attenuated in germ-free animals compared with WT-M, and studies such as from Desvarieux et al 19 and Chen et al 20 have shown that infection is associated with hypertension. Thus, reporting SFB status (negative in this case) is also essential. It is unlikely, however, that differences in infection contributed to the loss in phenotype because if anything, we have become more proficient at animal handling with time, and our facility has become cleaner rather than dirtier. Other important information to include in Methods sections of this article is the age of the breeders because the age of the dam and potentially the sire can affect the developmental programming of hypertension. 21 The 2 sources of genetic variation in inbred mouse strains are genetic contamination and genetic drift. Genetic contamination is the accidental intercrossing of mouse strains as a result of animal management errors. Jackson Laboratory, one of the major suppliers worldwide of inbred mouse strains, has a genetic quality control program (Genetic Stability Program) developed from over 85 years of experience that addresses this potential problem. 22 Thus, it is unlikely that the B6.Rag1 −/− -M loss of resistance to the Ang II pressor effect is because of an accidental intercrossing, especially because we consistently observed this loss over 6 separate purchases from Jackson Laboratory between March 2015 and October 2016.
The finding that there is a 1.4-fold higher level of angiotensin type 1-receptor binding to glomeruli in B6.Rag1 −/− -M purchased recently compared with B6.Rag1 −/− -M purchased before 2015 ( Figure 5 ) suggests that the loss of the Ang II-resistant blood pressure phenotype in the B6.Rag1 −/− -M mouse could be because of spontaneous mutations that directly increased renal mechanisms involving the angiotensin type 1-receptor by which Ang II increases blood pressure. Thus, these putative mutations may mask the mechanisms by which the absence of T cells protects the mice from Ang II-induced increases in blood pressure. Alternatively, the differences in mice purchased recently from those purchased before 2015 may be a result of dilution of unrelated 129S genome pieces left over from the original backcrosses.
Although inbred mouse strains are remarkably stable, genetic drift can occur through spontaneous and "quiet" mutations that can become fixed in mouse colonies. 23 Thus, this loss in resistance to the pressor effects of Ang II could be because of a spontaneous mutation(s) that makes the T-celldeficient B6.Rag1 em1Mcwi rat (SS.Rag1 −/− ) is a model of T-cell deficiency on a Dahl salt-sensitive background. 25 Mattson et al 25 demonstrated that these rats are less susceptible to the development of salt-sensitive hypertension. Twenty-one days of a high-sodium diet (4% NaCl) resulted in a 30 mm Hg increase in MAP in the SS.Rag1 −/− -M, which was much lower than the 50 mm Hg increase observed in male WT littermates. A year later in 2014, this laboratory showed similar results in a second Dahl salt-sensitive rat model of functional T-cell deficiency, the SS-Cd247 em1Mcwi rat (SS.CD247 −/− ). The CD247 gene codes for the CD3 ζ chain, which is required for T-cell signaling. Three weeks of salt loading increased MAP by only 12 mm Hg in the SS.CD247
−/− -M compared with 32 mm Hg in male WT littermates. 26 Both these studies suggest that in the absence of functional T cells, male Dahl salt-sensitive rats are less susceptible to developing salt-sensitive hypertension. Determining if these rats are also resistant to Ang II-induced increases in blood pressure could provide additional insight into the role of T cells in Ang II-dependent hypertension.
Even if the data on T-cell modulation of Ang II-dependent hypertension is questionable, there is strong evidence that T cells modulate other important physiological processes mediated by Ang II. Mian et al 13 showed that adoptive transfer of T-regulatory cells protected T cell reconstituted male B6.Rag1 −/− -deficient mice (CD3→B6.Rag1 −/− -M) from Ang II-induced endothelial dysfunction, although no differences in SBP were observed.
Whatever the case, accidental discovery of new phenotypes arising from quiet mutations can ultimately yield important insights for researchers. 23 For example, investigators discovered that a colony of C57BL/6 maintained at the Dunn School of Pathology in Oxford, UK, had nerves that were resistant to degeneration. 27 This led to the identification of the Wallerian degeneration slow (Wld) mutation 28 and now the C57BL/6OlaHsd-Wld is a widely studied model that has provided valuable insights into neural degeneration. Thus, investigating how the B6.Rag1 −/− -M mouse has lost its resistance to Ang II-dependent hypertension may also yield important information for those investigators studying the role of T cells in hypertension.
Perspectives
The most important aspect of this research is that T-celldeficient Rag1 −/− male mice on the C57BL/6J background (B6.Rag1 −/− -M) purchased from Jackson Laboratory as of 2015 are no longer a model of resistance to Ang II-induced hypertension. This phenotypic change affects the design of studies using this strain to study mechanisms of T-cell modulation of Ang II-dependent blood pressure control. Spontaneous mutations leading to phenotypic change is common in animals including inbred mouse strains as a result of the universal drive to increase genetic variation. Therefore, experimental details about the location and time period over which animals are bred should be reported in scientific method descriptions to promote rigor and reproducibility in the scientific literature.
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